Cullinan Therapeutics, Inc. · NASDAQ:CGEM

BVF PARTNERS L P/IL reported a 9.99% stake in Cullinan Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

BVF PARTNERS L P/IL reported a 9.99% stake in Cullinan Therapeutics, Inc., 5,918,481 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
5,918,481
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P5.60%3,302,376
BVF I GP LLC5.60%3,302,376
BIOTECHNOLOGY VALUE FUND II LP3.80%2,271,662
BVF II GP LLC3.80%2,271,662
Biotechnology Value Trading Fund OS LP0.40%224,641
BVF Partners OS Ltd.0.40%224,641
BVF GP HOLDINGS LLC9.40%5,574,038
BVF PARTNERS L P/IL9.99%5,918,481
BVF INC/IL9.99%5,918,481
LAMPERT MARK N9.99%5,918,481

Source

View original at SEC

Related